消化管間質腫瘍(GIST):世界の臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Gastrointestinal Stromal Tumor (GIST) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Gastrointestinal Stromal Tumor (GIST) 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Gastrointestinal Stromal Tumor (GIST) 35
Jun 11, 2013: Ariad Pharma Initiates Phase II Trial Of Ponatinib In Patients With Gastrointestinal Stromal Tumors 35
Nov 21, 2012: Regorafenib Overcomes Resistance In Patients With Gastrointestinal Stromal Tumor After Failure Of Standard Targeted Therapies, Researchers Report 35
Oct 24, 2012: EirGen Pharma’s Cancer Product Eir-108 Passes Clinical Trial In Japan 36
Jun 01, 2012: Clinical Trial Design Supports Original Accelerated Approval Of Sunitinib For GIST, Study Reports 36
Apr 03, 2012: Bayer Announces Positive Results From Phase III Trial Evaluating Regorafenib In Patients With Metastatic Gastrointestinal Stromal Tumors 37
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Novartis AG 39
Clinical Trial Overview of Novartis AG 39
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Bayer AG 45
Clinical Trial Overview of Bayer AG 45
AB Science 46
Clinical Trial Overview of AB Science 46
GlaxoSmithKline plc 47
Clinical Trial Overview of GlaxoSmithKline plc 47
Sarcoma Alliance for Research through Collaboration 48
Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration 48
Amgen Inc. 49
Clinical Trial Overview of Amgen Inc. 49
Infinity Pharmaceuticals, Inc. 50
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
AEterna Zentaris Inc. 52
Clinical Trial Overview of AEterna Zentaris Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
National Cancer Institute 53
Clinical Trial Overview of National Cancer Institute 53
European Organization for Research and Treatment of Cancer 56
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 56
The University of Texas M. D. Anderson Cancer Center 57
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 57
Stanford University 58
Clinical Trial Overview of Stanford University 58
Asan Medical Center 59
Clinical Trial Overview of Asan Medical Center 59
Radboud University 60
Clinical Trial Overview of Radboud University 60
Memorial Sloan Kettering Cancer Center 61
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 61
National University Hospital 62
Clinical Trial Overview of National University Hospital 62
Fox Chase Cancer Center 63
Clinical Trial Overview of Fox Chase Cancer Center 63
Technische Universitat Munchen 64
Clinical Trial Overview of Technische Universitat Munchen 64
Five Key Clinical Profiles 65
Appendix 160
Abbreviations 160
Definitions 160
Research Methodology 161
Secondary Research 161
About GlobalData 162
Contact Us 162
Disclaimer 162
Source 163


【レポート販売概要】

■ タイトル:消化管間質腫瘍(GIST):世界の臨床試験レビュー(2014年上半期)
■ 英文:Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2014
■ 発行日:2014年3月12日
■ 調査会社:GlobalData
■ 商品コード:GDHC2014CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。